Earnings Insights · Rocket Lab USA (RKLB) · Q3 FY2026

Rocket Lab USA (RKLB) Q3 FY2026: Rocket Lab Q3 2026 Earnings: Backlog Jumps to $3.6B as Neutron Demand Supports Higher Launch Pricing

By AlgovestIQ ResearchPublished

Share

Read Rocket Lab USA’s results announcement (Form 8-K, filed Nov 9, 2026)

Key earnings findings

Rocket Lab USA (RKLB) Q3 FY2026 · results discussed on the earnings call · Form 8-K filed

  1. Rocket Lab USA reported Q3 FY2026 revenue of $267.8M against the $257.2M analyst estimate, a 4.1% beat, and EPS of -$0.12 against the -$0.07 analyst estimate.
  2. Rocket Lab expects fourth-quarter revenue of $270M to $290M, implying 4.5% sequential growth at the midpoint and 55.9% year-over-year growth, according to management.
  3. RKLB closed at $62.71 on Nov 10, 2026, up 6.5% from $58.86 on Nov 9, 2026, the last close before the results were released.

Sources: Rocket Lab USA results announcement (SEC), the Q3 FY2026 earnings call, and AlgovestIQ reported-results and market data. All references

Did Rocket Lab USA beat earnings expectations?

Actual
Estimate
Surprise
Revenue
$267.8M
$257.2M
+4.1%
EPS
-$0.12
-$0.07
-82.5%
  • Revenue surprise across the last 8 reported quarters has ranged from 1.0% to 6.7%.

Reported figures against analyst estimates, compiled from AlgovestIQ data.

Rocket Lab reported record third-quarter revenue of $267.8M, up 73% year over year and 14.4% sequentially, while its GAAP net loss widened to $79.7M, or $0.12 per share. The quarter was defined less by the headline loss than by a sharp increase in contracted backlog, including substantial Neutron launch orders at higher prices, and by a fully funded path toward the pending Iridium acquisition.

The central investment question remains execution. Rocket Lab is converting strong demand across launch and space systems into revenue and improving gross profit, but Neutron’s first launch is now targeted for no earlier than 2027 and development spending remains the main constraint on near-term profitability and free cash flow.

As Reported on the Call

MetricReportedChange
Revenue$267.8MUp 73% year over year; up 14.4% sequentially
Space Systems revenue$214.8MUp 13.3% sequentially
Launch Services revenue$53.1MUp 19% sequentially
GAAP gross margin33.6%Above 29%-31% prior outlook
Non-GAAP gross margin38.4%Above 35%-37% prior outlook; down from 41.9% a year earlier
GAAP operating loss$79.2MCompared with $59.0M loss a year earlier
Net loss$79.7MCompared with $18.3M loss a year earlier
GAAP EPS$(0.12)Compared with $(0.03) a year earlier
Adjusted EBITDA loss$18.0MImproved from $26.3M loss a year earlier
GAAP operating cash flow$7.2MCompared with $84.1M cash use in Q2
Non-GAAP free cash flow$(23.9M)Compared with $(110.1M) use in Q2
Total backlogApproximately $3.6BUp 52% sequentially
Launch backlog117 launchesRecord level
Cash, restricted cash and marketable securitiesApproximately $4.7BIncreased following equity issuance

The Bigger Story

Rocket Lab’s backlog rose from approximately $2.4B at the end of the second quarter to $3.57B at the end of September, supported by more than $1B of new launch contracts and $470M of Space Systems awards signed during the quarter. Launch represented roughly 52% of backlog, with Space Systems accounting for 48%.

The most consequential element was Neutron demand before the vehicle’s debut. Rocket Lab signed eight Neutron missions worth roughly $515M during the quarter, taking Neutron’s contracted backlog to 16 missions. Management said several contracts were signed at a new base launch price of $70M, reflecting constrained medium-lift launch supply.

That demand improves the long-term economic case for Neutron, but it does not eliminate the program’s execution risk. The company shifted Neutron’s first launch target to no earlier than 2027 after identifying voids in a Stage 1 propellant-tank dome. Management said a replacement forward dome has completed its cure cycle and that Stage 1 tank assembly, testing, engine qualification, ground-system work and vehicle integration are progressing in parallel.

Revenue and Operating Performance

Third-quarter revenue reached $267.8M, exceeding Rocket Lab’s prior $250M-$265M guidance range. The company has now posted six consecutive quarters of record revenue.

Space Systems remained the primary revenue engine, contributing $214.8M, or about 80% of quarterly revenue. The segment grew 13.3% sequentially, led by continued scaling in satellite platforms and full-quarter contributions from the laser communications and robotics acquisitions. Management also cited organic growth across component and software operations.

Launch Services generated $53.1M, up 19% sequentially. The increase was driven by two additional Electron missions whose revenue is recognized at launch. This illustrates a difference in revenue timing across Rocket Lab’s operations: launch revenue can be uneven because point-in-time missions depend on launch timing, while satellite-platform and component work is generally recognized over longer program periods.

Operationally, Rocket Lab said it launched 12 company-built spacecraft over the past 12 months and had more than 55 spacecraft in development or production at quarter-end. Its Electron production system is now producing an average of one rocket every eight workdays, according to management, while the company expects Electron’s 100th launch within weeks of the earnings call.

Profitability and Margins

GAAP gross margin was 33.6%, above Rocket Lab’s 29%-31% prior outlook. Non-GAAP gross margin was 38.4%, also ahead of the company’s 35%-37% forecast.

Margins declined sequentially, however, due partly to the first full-quarter contribution from Mynaric, Rocket Lab’s laser communications acquisition, and the absence of tariff refunds that benefited second-quarter margins. Management said Mynaric will require several quarters to reach its target margin structure as Rocket Lab aligns costs and scales production.

Those pressures were partly offset by stronger-than-expected profitability in component businesses, notably solar and optical systems, as well as improved launch-cost absorption. Higher Electron launch and production cadence reduced the burden of fixed costs per mission.

Rocket Lab’s GAAP operating loss widened to $79.2M from $59.0M a year earlier. The GAAP net loss widened to $79.7M from $18.3M, while GAAP loss per share was $0.12 versus $0.03 a year earlier. The larger reported loss reflected increased development spending, transaction costs tied to the Iridium acquisition, and a $27.3M loss on debt extinguishment.

Adjusted EBITDA improved year over year but remained negative at $18.0M, compared with a $26.3M loss in the prior-year quarter. Rocket Lab also recorded a forward-loss reserve related to Neutron Flight 2, reflecting the early-stage economics and uncertainty surrounding that specific mission.

The company’s near-term earnings profile remains heavily influenced by Neutron development. Research and development expense rose to $98.4M from $70.7M a year earlier, driven by engine production, composite structures, and other Flight 1 activities. Management expects Neutron spending to remain elevated through the first launch.

Demand, Customers and Pricing

The backlog increase was broad-based. Rocket Lab signed 54 launch contracts in the quarter, including an 18-launch HASTE order for the U.S. Space Force’s Space Systems Command and a 20-launch Electron order from customer Synspective. Those contracts helped take total launch backlog to 117 missions.

Management expects approximately 32.9% of total backlog at quarter-end to convert into revenue over the next 12 months. That conversion rate is meaningful, though a large share of the Neutron backlog extends into later years. Management said the next available Neutron launch slots are now in the 2030s, although Rocket Lab intends to retain capacity for its own future space-services missions.

The company sees room for higher pricing across Electron, HASTE and Neutron as launch capacity tightens. Management characterized the $70M Neutron base price as already established in backlog rather than merely a future target, and said it turned down some additional Neutron volume in favor of preserving capacity for potentially higher-value contracts.

HASTE is becoming a larger part of launch backlog and carries a higher average selling price than standard Electron missions. Management indicated that approximately 25% of dedicated launches next year could be HASTE missions, although actual cadence will depend on customers completing payloads on schedule.

What is Rocket Lab’s guidance for Q4 2026?

Rocket Lab expects fourth-quarter revenue of $270M to $290M, implying 4.5% sequential growth at the midpoint and 55.9% year-over-year growth, according to management.

The company expects:

  • GAAP gross margin: 34% to 36%
  • Non-GAAP gross margin: 39% to 41%
  • GAAP operating expenses: $162M to $168M
  • Non-GAAP operating expenses: $136M to $142M
  • Net interest income: $45M
  • Adjusted EBITDA loss: $14M to $20M
  • Basic weighted-average shares outstanding: approximately 681 million

Management guided fourth-quarter GAAP operating expenses to $162M to $168M and non-GAAP operating expenses to $136M to $142M, with the sequential increase driven mainly by Neutron development testing and readiness work ahead of Flight 1. It expects fourth-quarter net interest income of about $45M, largely a function of its elevated cash balance.

Management expects stronger launch revenue from both point-in-time and over-time recognition. Space Systems revenue is expected to decline from a particularly strong third quarter as solar and satellite-platform revenue moderates, although the company expects growth in its other Space Systems businesses.

Gross margin is expected to improve sequentially, aided by a more favorable mix between launch and Space Systems revenue. Operating expenses are expected to rise as Neutron development, test and flight-readiness activity accelerates.

Balance Sheet, Cash Flow and Capital

Rocket Lab ended the quarter with approximately $4.7B in cash, cash equivalents, restricted cash and marketable securities, compared with roughly $1.1B at year-end 2025. The liquidity increase was primarily driven by at-the-market equity offerings.

The company raised approximately $2.4B in gross proceeds during the third quarter through the issuance of 36.8 million shares under its ATM program. For the first nine months of 2026, ATM offerings generated $3.9B in gross proceeds. Common shares outstanding increased to 639.2 million at September 30 from 543.6 million at December 31, 2025, underscoring the dilution accompanying the stronger balance sheet.

Management said the completed equity financing, together with Iridium’s amended term-loan facility and Rocket Lab’s available liquidity, fully funds the cash consideration and other requirements for the pending Iridium acquisition. Rocket Lab has therefore terminated its $3.6B bridge-financing commitment. Iridium shareholders have approved the transaction, while regulatory approvals remain outstanding.

Operating cash flow turned positive at $7.2M in the quarter after an $84.1M outflow in the second quarter, primarily because satellite-program milestone payments increased. That improvement should not be read as a sustained shift yet. For the first nine months of 2026, operating cash flow was negative $127.3M, while investing cash outflow was $113.9M.

Capital expenditures were $31.1M in the third quarter and are expected to remain elevated as Rocket Lab invests in Neutron testing, production capacity, launch infrastructure and longer-lead items for government programs. Management continues to expect negative non-GAAP free cash flow in the fourth quarter.

What Investors Should Watch

1. Neutron’s path from testing to a defined 2027 launch window

The replacement Stage 1 tank dome has moved forward, but the company has not provided a more specific first-launch date. Completing tank tests, engine qualification, vehicle integration and launch-site testing without further schedule movement is the key execution milestone.

2. Neutron’s launch cadence after Flight 1

The company has 16 Neutron missions contracted and sees demand exceeding available capacity. However, the economics depend on scaling flight rate after the initial test flight, not simply achieving a first launch. Management has said it is evaluating ways to accelerate engine and composite-structure production.

3. Launch pricing and backlog quality

Higher pricing for Neutron, Electron and HASTE could materially improve long-term launch margins. Investors should watch whether Rocket Lab can sustain $70M-or-higher Neutron pricing while preserving contract discipline and converting deposits and contracts into actual launches.

4. Space Systems growth after a strong quarter

Space Systems produced nearly 80% of third-quarter revenue, but fourth-quarter results are expected to decline sequentially in solar and satellite platforms. The question is whether component, software and platform programs can support consistent growth despite the inherently lumpy timing of large contract awards.

5. Iridium closing and capital allocation

Rocket Lab has funded the acquisition, but the transaction still requires regulatory clearance. Investors should monitor closing timing, the pace of integration, and whether the acquired recurring cash flow offsets Rocket Lab’s continuing Neutron investment and recent share dilution.

AlgovestIQ Takeaway

Rocket Lab’s third quarter strengthened the long-term demand case. Revenue growth remained high, gross margin exceeded guidance, and the backlog expanded by more than $1.2B in one quarter despite a substantially higher revenue run rate. The Neutron orders are particularly important because they validate customer willingness to commit to a vehicle still in development and suggest constrained launch supply is supporting higher prices.

The financial tradeoff is clear. Rocket Lab is using a much larger equity base and elevated operating investment to fund both Neutron and the pending Iridium acquisition. Its cash position is substantial, and the company has removed the need for additional acquisition financing, but shareholders have absorbed material dilution to reach that position.

Neutron remains the central variable in the investment case. The program’s backlog, pricing and eventual reusable-rocket economics could reshape Rocket Lab’s growth and margin profile. Yet the first launch has moved into 2027, and profitability will remain constrained while engineering, testing, production and launch infrastructure costs stay elevated.

Evidence that would strengthen the thesis includes a stable Neutron schedule, successful completion of major qualification milestones, continued premium launch pricing, and sustained Space Systems growth outside a handful of large programs. Further Neutron delays, weaker conversion of backlog into revenue, or persistent cash consumption after development spending should begin to shift into production would weaken the case.

How did RKLB stock react?

RKLB closed at $62.71 on Nov 10, 2026, up 6.5% from $58.86 on Nov 9, 2026, the last close before the results were released.

SessionCloseChange
Nov 9, 2026 (before release)$58.86—
Nov 10, 2026$62.71+6.5%

Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.

More from this earnings season

References

  1. Management commentary, analyst questions and outlook discussed on the call. Source: Rocket Lab USA Q3 FY2026 earnings call transcript, as of Nov 9, 2026.
  2. Reported results, segment figures and guidance from the company's results announcement. Source: Rocket Lab USA Form 8-K, Item 2.02 (SEC EDGAR), as of Nov 9, 2026.
  3. Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Nov 9, 2026.

AI-generated analysis based on company-reported earnings data and earnings-call materials. Every reported figure is checked against Rocket Lab USA's earnings release and call transcript before publication. Not investment advice.